XML 14 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover Page - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Mar. 30, 2022
Jun. 30, 2021
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2021    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-36856    
Entity Registrant Name HEPION PHARMACEUTICALS, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 46-2783806    
Entity Address, Address Line One 399 Thornall Street    
Entity Address, Address Line Two First Floor    
Entity Address, City or Town Edison    
Entity Address, State or Province NJ    
Entity Address, Postal Zip Code 08837    
City Area Code 732    
Local Phone Number 902-4000    
Title of 12(b) Security Common Stock, par value $0.0001 per share    
Trading Symbol HEPA    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Entity Shell Company false    
Entity Public Float     $ 150.8
Entity Common Stock, Shares Outstanding   76,229,571  
Documents Incorporated by Reference Parts of the registrant’s Proxy Statement for the Registrant’s 2022 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K. Such Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant's fiscal year ended December 31, 2021.    
Entity Central Index Key 0001583771    
Document Fiscal Year Focus 2021    
Document Fiscal Period Focus FY    
Amendment Flag false    
Entity Filer Category Non-accelerated Filer